The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?

Author： Baribaud Frédéric   Doms Robert W   Pöhlmann Stefan  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.4, 2002-08, pp. : 423-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DC-SIGN Antagonists, a Potential New Class of Anti-Infectives

By  

Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. : 992-1007

Bentham Science Publishers

Access to resources Recommend Favorite

NAPc2 prolongs survival in Ebola virus infection

By  

Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Antibody therapy as a future treatment option for Ebola virus infection

By Matsuno Keita   Takada Ayato  

Future Virology, Vol. 2, Iss. 6, 2007-11 ,pp. : 607-614

Future Medicine

Access to resources Recommend Favorite

The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 361-370

Bentham Science Publishers

Access to resources Recommend Favorite

Heroin Dependence and Bloodborne Virus Transmission Behaviors for HIV Infection Among Newly Incarcerated Injection Drug Users in Taiwan

By Ko Nai-Ying   Hsu Su-Ting   Chen Cheng-Hui   Lee Hsin-Chun   Ko Wen-Chien  

Substance Use & Misuse, Vol. 46, Iss. 5, 2011-03 ,pp. : 591-598

Informa Healthcare

Access to resources Recommend Favorite